Lutein and zeaxanthin for reducing morbidity and mortality in preterm infants

To assess the effectiveness of lutein and zeaxanthin supplementation used for reducing morbidity and mortality in preterm infants, to assess any adverse effects of lutein and zeaxanthin for this purpose, and to consider the effect of the supplementation in terms of route, dose and timing.

This is a protocol.

Share/Save